Fol. Biol. 2005, 51, 177-179
https://doi.org/10.14712/fb2005051060177
The Use of Comparative Duplex PCR in Monitoring of Patients with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia
References
1. , G. (2001) Detection of minimal residual disease. Adv. Cancer Res. 2, 133-185.
<https://doi.org/10.1016/S0065-230X(01)82005-4>
2. , J. G. (2002) Monitoring disease in lymphoma and CLL patients using molecular techniques. Baillieres Best Pract. Res. Clin. Haematol. 15, 179-195.
<https://doi.org/10.1053/beha.2002.0191>
3. , T. (1994) Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. Bone Marrow Transplant. 14, 505-509.
4. , S. A., Dykes, D. D., Polesky, H. F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acid Res. 1, 1215-1217.
<https://doi.org/10.1093/nar/16.3.1215>
5. , M., Neumeister, P., Kalhs, P. (2001) Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma. Leukemia 15, 635-641.
<https://doi.org/10.1038/sj.leu.2402053>
6. , A., Ullmannová, V., Benešová, E., Klener, P. (1999) Monitoring of residual disease in non-Hodgkins' lymphomas by quantitative PCR. Folia Biol. (Praha) 45, 179-183.
7. , A., Ullmannova, V., Klener, P. (2000) Optimised multiplex IgH/ras PCR: A tool for quantitative monitoring of B-lymphoproliferative disorders. BioTechniques 28, 716-721.
<https://doi.org/10.2144/00284st08>
